China
300294.SZChina Resources Boya Bio-pharmaceutical Group Co., Ltd. Price (300294.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
505,245,944
(0.1978)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
China Resources Boya Bio-pharmaceutical Group Co., Ltd.Currency: CNY
| YEAR | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
90,168,286.00
+0% |
119,723,394.00
+33% |
141,823,513.00
+18% |
196,724,566.00
+39% |
227,259,439.00
+16% |
245,278,066.00
+8% |
437,792,952.00
+78% |
543,182,670.00
+24% |
946,596,099.00
+74% |
1,460,521,856.00
+54% |
2,387,519,494.00
+63% |
2,760,925,046.00
+16% |
2,513,038,687.00
-9% |
2,650,528,421.00
+5% |
2,758,701,315.00
+4% |
2,651,979,506.00
-4% |
|||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 29,946,818.00 | 38,186,775.00 | 41,725,503.00 | 70,694,397.00 | 93,186,848.00 | 106,274,429.00 | 167,591,887.00 | 194,947,754.00 | 349,889,888.00 | 491,235,667.00 | 863,296,460.00 | 976,574,216.00 | 1,053,623,626.00 | 1,140,199,779.00 | 1,250,871,479.00 | 1,252,860,597.00 | |||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
60,221,468.00
+0% |
81,536,619.00
+35% |
100,098,010.00
+23% |
126,030,169.00
+26% |
134,072,591.00
+6% |
139,003,637.00
+4% |
270,201,065.00
+94% |
348,234,916.00
+29% |
596,706,211.00
+71% |
969,286,189.00
+62% |
1,524,223,034.00
+57% |
1,784,350,830.00
+17% |
1,459,415,061.00
-18% |
1,510,328,642.00
+3% |
1,507,829,836.00
0% |
1,399,118,909.00
-7% |
|||
| Gross Profit Ratio | (0.67%) | (0.68%) | (0.71%) | (0.64%) | (0.59%) | (0.57%) | (0.62%) | (0.64%) | (0.63%) | (0.66%) | (0.64%) | (0.65%) | (0.58%) | (0.57%) | (0.55%) | (0.53%) | |||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 6,814,507.00 | 9,082,707.00 | 8,871,394.00 | 11,055,557.00 | 14,218,313.00 | 16,643,659.00 | 23,894,818.00 | 42,413,224.00 | 34,531,383.00 | 45,057,068.00 | 92,758,004.00 | 89,048,596.00 | 59,293,842.00 | 49,581,282.00 | 80,951,508.00 | |||
| General and Administrative | 19,100,085.00 | 12,933,756.00 | 13,117,302.00 | 19,014,668.00 | 24,180,095.00 | 18,850,503.00 | 26,014,257.00 | 30,977,684.00 | 45,817,328.00 | 39,811,925.00 | 52,337,788.00 | 60,536,826.00 | 58,872,576.00 | 59,372,906.00 | 41,038,890.00 | 49,063,534.00 | |||
| Selling, General & Admin... | 21,524,369.00 | 17,358,083.00 | 18,857,704.00 | 25,567,658.00 | 32,054,298.00 | 26,581,831.00 | 90,506,262.00 | 106,847,855.00 | 159,231,031.00 | 417,744,196.00 | 806,925,054.00 | 1,024,094,751.00 | 925,115,435.00 | 829,722,551.00 | 738,315,875.00 | 777,226,035.00 | |||
| Selling & Marketing Exp... | 2,424,283.00 | 4,424,326.00 | 5,740,401.00 | 6,552,990.00 | 7,874,203.00 | 7,731,327.00 | 64,492,004.00 | 75,870,171.00 | 113,413,702.00 | 377,932,270.00 | 754,587,266.00 | 963,557,925.00 | 866,242,859.00 | 770,349,645.00 | 697,276,984.00 | 538,812,453.00 | |||
| Depreciation and Amortiz... | 3,751,198.00 | 7,251,117.00 | 17,092,918.00 | 16,526,247.00 | 17,615,704.00 | 19,182,980.00 | 26,876,200.00 | 29,947,542.00 | 49,803,163.00 | 52,290,872.00 | 67,031,292.00 | 93,941,573.00 | 94,598,151.00 | 112,977,481.00 | 110,717,883.00 | 113,911,195.00 | |||
| Other Expenses | -15,779,715.03 | 665,556.00 | 6,382,473.00 | 8,331,242.00 | -5,389,663.54 | 3,929,709.00 | 6,714,283.00 | 6,196,964.00 | 2,888,261.00 | 1,254,423.00 | 7,708,054.00 | 5,922,549.00 | -3,325,584.41 | 10,775,684.00 | -179,005.70 | 179,884,675.00 | |||
| Total Operating Expenses | 22,459,789.00 | 35,942,478.00 | 41,793,360.00 | 51,393,824.00 | 62,962,276.00 | 62,202,555.00 | 145,365,049.00 | 186,412,055.00 | 280,244,293.00 | 554,195,044.00 | 947,896,909.00 | 1,245,019,768.00 | 1,127,264,780.00 | 1,040,844,971.00 | 985,598,513.00 | 1,038,062,218.00 | |||
| Cost and Exponses | 52,406,607.00 | 74,129,253.00 | 83,518,863.00 | 122,088,222.00 | 156,149,124.00 | 168,476,985.00 | 312,956,936.00 | 381,359,810.00 | 630,134,182.00 | 1,045,430,712.00 | 1,811,193,370.00 | 2,221,593,984.00 | 2,180,888,406.00 | 2,181,044,751.00 | 2,236,469,993.00 | 2,296,754,446.00 | |||
| Operating Income | |||||||||||||||||||
| Operating Income |
33,895,074.00
+0% |
42,526,403.00
+25% |
53,577,301.00
+26% |
71,642,469.00
+34% |
82,556,925.00
+15% |
93,831,230.00
+14% |
129,392,868.00
+38% |
192,290,155.00
+49% |
325,662,225.00
+69% |
429,355,644.00
+32% |
564,536,074.00
+31% |
514,115,786.00
-9% |
331,456,105.00
-36% |
443,056,519.00
+34% |
532,180,673.00
+20% |
355,225,060.00
-33% |
|||
| Operating Income Ratio | (0.38%) | (0.36%) | (0.38%) | (0.36%) | (0.36%) | (0.38%) | (0.30%) | (0.35%) | (0.34%) | (0.29%) | (0.24%) | (0.19%) | (0.13%) | (0.17%) | (0.19%) | (0.13%) | |||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | -0.96 | -0.10 | 703,495.00 | 556,114.00 | 12,607,619.00 | 17,150,465.00 | 10,794,973.00 | 8,412,263.00 | 10,358,107.00 | 10,921,355.00 | 16,592,049.00 | 13,932,954.00 | 12,823,451.00 | 31,501,691.00 | 26,200,491.00 | 31,293,144.00 | |||
| Interest Expenses | 4,208,622.00 | 2,717,371.00 | 5,747,162.00 | 3,662,761.00 | 1,066,083.00 | 73,422.00 | 187,141.00 | 1,119,267.00 | 349,007.00 | 1,538,780.00 | 23,977,807.00 | 30,760,165.00 | 21,451,175.00 | 10,529,939.00 | 622,913.00 | 800,539.00 | |||
| Total Other Income/Exp... | -15,779,715.00 | -2,483,883.00 | 666,056.00 | 5,191,823.00 | 6,104,241.00 | 3,928,118.00 | 6,516,383.00 | 7,978,007.00 | 2,583,127.00 | 1,254,430.00 | 7,708,059.00 | 5,922,550.00 | -3,325,582.00 | 61,388.00 | -179,005.00 | -1,513,272.00 | |||
| EBITDA | |||||||||||||||||||
| EBITDA | 37,761,678.00 | 52,845,258.00 | 82,120,531.00 | 96,888,310.00 | 107,342,950.00 | 116,875,629.00 | 162,972,587.00 | 228,656,951.00 | 378,325,598.00 | 490,783,676.00 | 667,832,045.00 | 631,819,276.00 | 436,277,676.00 | 552,645,049.00 | 643,641,627.00 | 468,423,526.00 | |||
| EBITDA ratio | (0.42%) | (0.45%) | (0.58%) | (0.49%) | (0.47%) | (0.48%) | (0.38%) | (0.42%) | (0.40%) | (0.33%) | (0.28%) | (0.23%) | (0.17%) | (0.24%) | (0.25%) | (0.18%) | |||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 18,115,359.00 | 42,654,238.00 | 59,280,450.00 | 76,834,292.00 | 88,661,166.00 | 97,759,343.00 | 135,909,246.00 | 197,590,141.00 | 328,152,816.00 | 430,610,068.00 | 572,244,129.00 | 520,038,336.00 | 328,130,521.00 | 443,117,907.00 | 532,001,667.00 | 353,711,788.00 | |||
| Income Before Tax Ratio | (0.20%) | (0.36%) | (0.42%) | (0.39%) | (0.39%) | (0.40%) | (0.31%) | (0.36%) | (0.35%) | (0.29%) | (0.24%) | (0.19%) | (0.13%) | (0.17%) | (0.19%) | (0.13%) | |||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 7,458,977.00 | 11,148,460.00 | 9,303,980.00 | 11,600,220.00 | 13,514,976.00 | 15,398,219.00 | 20,705,121.00 | 30,545,004.00 | 50,598,091.00 | 65,678,881.00 | 87,164,493.00 | 77,915,058.00 | 52,869,025.00 | 84,838,744.00 | 86,513,859.00 | 105,563,390.00 | |||
| Net Income | |||||||||||||||||||
| Net Income | 10,713,309.00
+0% |
31,478,636.00
+194% |
49,976,470.00
+59% |
65,234,071.00
+31% |
75,146,190.00
+15% |
82,403,126.00
+10% |
104,179,698.00
+26% |
151,798,745.00
+46% |
272,041,808.00
+79% |
356,588,468.00
+31% |
469,174,808.00
+32% |
426,146,775.00
-9% |
260,060,146.00
-39% |
344,528,999.00
+32% |
432,197,553.00
+25% |
237,465,593.00
-45% |
|||
| Net Income Ratio | (0.12%) | (0.26%) | (0.35%) | (0.33%) | (0.33%) | (0.34%) | (0.24%) | (0.28%) | (0.29%) | (0.24%) | (0.20%) | (0.15%) | (0.10%) | (0.13%) | (0.16%) | (0.09%) | |||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.05 | 0.14 | 0.20 | 0.26 | 0.24 | 0.24 | 0.31 | 0.44 | 1.02 | 0.89 | 1.11 | 1.00 | 0.61 | 0.79 | 0.86 | 0.47 | |||
| Diluted EPS | 0.05 | 0.14 | 0.20 | 0.26 | 0.24 | 0.24 | 0.31 | 0.44 | 1.02 | 0.89 | 1.11 | 1.00 | 0.61 | 0.79 | 0.86 | 0.47 | |||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 200,874,548.00 | 217,929,025.00 | 255,561,494.00 | 255,263,759.00 | 319,016,845.00 | 340,196,392.00 | 339,716,408.00 | 343,865,786.00 | 266,707,656.00 | 400,661,200.00 | 422,680,007.00 | 426,146,775.00 | 425,940,163.00 | 436,112,657.00 | 504,248,738.00 | 505,245,944.00 | |||
| Diluted Share Outstanding | 200,874,548.00 | 217,929,025.00 | 255,561,494.00 | 255,263,759.00 | 319,016,845.00 | 340,196,392.00 | 339,716,408.00 | 344,997,148.00 | 266,707,656.00 | 400,661,200.00 | 422,680,007.00 | 426,146,775.00 | 425,940,163.00 | 436,112,657.00 | 504,248,738.00 | 505,245,944.00 | |||